Chairman James Huang of the Taiwan External Trade Development Council stated that Taiwan is a global leader in the semiconductor and ICT industries and plays a central role in the AI technology revolution, establishing a unique competitive advantage in precision medicine. In the face of an aging population and unpredictable medical challenges caused by climate anomalies, Taiwan actively leverages AI-driven solutions to enhance early diagnosis and improve treatment efficiency. Notably, the Taiwanese government utilizes its robust technological infrastructure and strict data privacy protections, along with AI and precision medical technology, to make advanced medical services more accessible, bridging global healthcare gaps and showcasing Taiwan's impact on the global medical industry.



At the press conference, iNtRON Biotechnology unveiled an AI-integrated surgical navigation robot that can rapidly localize and adapt to various stereotactic brain surgeries. MicroBase Technology introduced an innovative nebulization system with a corner-free medication cup design, offering respiratory therapy solutions for long-term care and intensive care units. Apex Medical presented a customized 3D-printed joint solution that shortens surgery duration and enhances surgical precision and success rates. Endosemio debuted the world’s first wireless endoscopic imaging tracheostomy kit, providing clear and stable real-time imaging guidance at the tip of the tracheostomy tube. Its single-use design ensures patient safety.